Who should not take GLP-1 medicines
Significant weight loss usually occurs within 3 to 6 months , with maximum benefits seen after one year of consistent use
Lenzi A, Lombardo F, Sgro P, Salacone P, Caponecchia L, Dondero F, Gandini L Use of carnitine therapy in selected cases of male factor infertility: a double-blind crossover trial.
The PCAC is currently meeting to discuss seven peptides: BPC-157 KPV TB-500 MOTS-c Emideltide (also called DSIP) Semax Epitalon These peptides (plus five more) were previously on the 503A Bulk Drug Substances list, meaning they were able to be prescribed and compounded
3 GLP-1s anti-inflammatory properties Recent scientific research has increasingly highlighted the potential anti-inflammatory role of GLP-1
They may encourage set and forget thinking